Literature DB >> 16125154

Influence of EGF/bFGF treatment on proliferation, early neurogenesis and infarct volume after transient focal ischemia.

Kathrin Baldauf1, Klaus G Reymann.   

Abstract

The persistence of neurogenesis in the adult mammalian forebrain suggests that endogenous precursors may be a potential source for neuronal replacement after injury or neurodegeneration. On the other hand basic fibroblast growth factor (bFGF) and epidermal growth factor (EGF) can facilitate neural precursor proliferation in the adult rodent subventricular zone (SVZ) and dentate gyrus. As the application of EGF and bFGF was found to boost neurogenesis after global ischemia, in this study we investigated whether a combined intracerebroventricular (i.c.v.) EGF/bFGF treatment over a period of 2 weeks affects the proliferation of newly generated cells in the endothelin-1 model of transient focal ischemia in adult male Sprague-Dawley rats as well. As assessed by toluidine blue staining, EGF/bFGF substantially increased the infarct volume in ischemic animals. Chronic 5'-bromodeoxyuridine (BrdU) i.c.v. application revealed an EGF/bFGF-induced increase in cell proliferation in the lateral ventricle 14 days after surgery. Proliferation in the striatum increased after ischemia, whereas in the dentate gyrus and in the dorsal 3rd ventricle the number of cells decreased. Analysis of the neuronal fate of these cells by co-staining with a doublecortin (DCX) antibody showed that the growth factors concomitantly nearly doubled early neurogenesis in the ipsilateral striatum in ischemic animals but diminished it in the dentate gyrus. Because of the increased infarct volume and unclear long-term outcome further modifications of a chronic treatment schedule are needed before final conclusions concerning the perspectives of such an approach can be made.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16125154     DOI: 10.1016/j.brainres.2005.07.035

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  24 in total

1.  FGF2 gene transfer restores hippocampal functions in mouse models of Alzheimer's disease and has therapeutic implications for neurocognitive disorders.

Authors:  Tomomi Kiyota; Kaitlin L Ingraham; Michael T Jacobsen; Huangui Xiong; Tsuneya Ikezu
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-31       Impact factor: 11.205

2.  Neurogenesis in Alzheimer´s disease: a realistic alternative to neuronal degeneration?

Authors:  Rocío E Gonzalez-Castaneda; Alma Y Galvez-Contreras; Sonia Luquín; Oscar Gonzalez-Perez
Journal:  Curr Signal Transduct Ther       Date:  2011-09-01

Review 3.  Growth factors and stroke.

Authors:  David A Greenberg; Kunlin Jin
Journal:  NeuroRx       Date:  2006-10

4.  Protective effect of estrogen in endothelin-induced middle cerebral artery occlusion in female rats.

Authors:  Michele L Glendenning; Tara Lovekamp-Swan; Derek A Schreihofer
Journal:  Neurosci Lett       Date:  2008-09-06       Impact factor: 3.046

Review 5.  Neurogenesis in Stroke Recovery.

Authors:  Seong-Ho Koh; Hyun-Hee Park
Journal:  Transl Stroke Res       Date:  2016-03-18       Impact factor: 6.829

6.  The effect of aging on the density of the sensory nerve fiber innervation of bone and acute skeletal pain.

Authors:  Juan M Jimenez-Andrade; William G Mantyh; Aaron P Bloom; Katie T Freeman; Joseph R Ghilardi; Michael A Kuskowski; Patrick W Mantyh
Journal:  Neurobiol Aging       Date:  2010-10-13       Impact factor: 4.673

Review 7.  Neural stem cell therapies and hypoxic-ischemic brain injury.

Authors:  Lei Huang; Lubo Zhang
Journal:  Prog Neurobiol       Date:  2018-05-21       Impact factor: 11.685

8.  Microglia cells protect neurons by direct engulfment of invading neutrophil granulocytes: a new mechanism of CNS immune privilege.

Authors:  Jens Neumann; Steven Sauerzweig; Raik Rönicke; Frank Gunzer; Klaus Dinkel; Oliver Ullrich; Matthias Gunzer; Klaus G Reymann
Journal:  J Neurosci       Date:  2008-06-04       Impact factor: 6.167

9.  Neurogenesis associated with endothelin-induced cortical infarction in the mouse.

Authors:  Yaoming Wang; Kunlin Jin; David A Greenberg
Journal:  Brain Res       Date:  2007-07-17       Impact factor: 3.252

10.  Cell encapsulation enhances antidepressant effect of the mesenchymal stem cells and counteracts depressive-like behavior of treatment-resistant depressed rats.

Authors:  Kyohei Kin; Takao Yasuhara; Masahiro Kameda; Yousuke Tomita; Michiari Umakoshi; Ken Kuwahara; Ittetsu Kin; Naoya Kidani; Jun Morimoto; Mihoko Okazaki; Tatsuya Sasaki; Naoki Tajiri; Cesario V Borlongan; Isao Date
Journal:  Mol Psychiatry       Date:  2018-08-14       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.